Seneca Biopharma, Inc.·4

Apr 26, 7:52 PM ET

Csimma Cristina 4

4 · Seneca Biopharma, Inc. · Filed Apr 26, 2021

Insider Transaction Report

Form 4
Period: 2021-04-01
Transactions
  • Award

    Restricted Stock Units

    2021-04-01+6,0006,000 total
    Common Stock (6,000 underlying)
Footnotes (2)
  • [F1]Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

Documents

1 file
  • 4
    ownership.xmlPrimary